Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
As of close of business last night, Nautilus Biotechnology Inc’s stock clocked out at $2.27, up 3.65% from its previous closing price of $2.19. In other words, the price has increased by $3.65 from its previous closing price. On the day, 0.29 million shares were traded. NAUT stock price reached its highest trading level at $2.3 during the session, while it also had its lowest trading level at $2.103.
Ratios:
To gain a deeper understanding of NAUT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 14.95 and its Current Ratio is at 14.95. In the meantime, Its Debt-to-Equity ratio is 0.16 whereas as Long-Term Debt/Eq ratio is at 0.13.
On June 27, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $6.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 06 ’25 when Suzuki Kentaro bought 4,000 shares for $1.49 per share. The transaction valued at 5,960 led to the insider holds 4,000 shares of the business.
Patel Sujal M bought 116,500 shares of NAUT for $78,544 on Sep 05 ’25. The CEO, President, and Secretary now owns 10,258,221 shares after completing the transaction at $0.67 per share. On Sep 08 ’25, another insider, Patel Sujal M, who serves as the CEO, President, and Secretary of the company, bought 83,500 shares for $0.68 each. As a result, the insider paid 57,031 and bolstered with 10,341,721 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NAUT now has a Market Capitalization of 286712608 and an Enterprise Value of 182288624.
Stock Price History:
The Beta on a monthly basis for NAUT is 1.32, which has changed by -0.022321403 over the last 52 weeks, in comparison to a change of 0.12159383 over the same period for the S&P500. Over the past 52 weeks, NAUT has reached a high of $2.54, while it has fallen to a 52-week low of $0.62. The 50-Day Moving Average of the stock is 71.17%, while the 200-Day Moving Average is calculated to be 134.40%.
Shares Statistics:
It appears that NAUT traded 510.15K shares on average per day over the past three months and 447000 shares per day over the past ten days. A total of 126.31M shares are outstanding, with a floating share count of 60.06M. Insiders hold about 52.45% of the company’s shares, while institutions hold 25.80% stake in the company. Shares short for NAUT as of 1763078400 were 390590 with a Short Ratio of 0.77, compared to 1760486400 on 180291. Therefore, it implies a Short% of Shares Outstanding of 390590 and a Short% of Float of 0.7900001.
Earnings Estimates
Investors are keenly observing as 2.0 analysts analyze and rate. The current performance of Nautilus Biotechnology Inc (NAUT) in the stock market.The consensus estimate for the next quarter is -$0.17, with high estimates of -$0.15 and low estimates of -$0.18.
Analysts are recommending an EPS of between -$0.5 and -$0.55 for the fiscal current year, implying an average EPS of -$0.52. EPS for the following year is -$0.61, with 2.0 analysts recommending between -$0.56 and -$0.66.
